Calidi Biotherapeutics, Inc.Calidi Biotherapeutics, Inc.Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc.

No trades
Buy CLDI

CLDI fundamentals

Calidi Biotherapeutics, Inc. earnings per share and revenue

CLDI earnings per share for the last quarter are -1.40 USD whereas the estimation was -1.45 USD which accounts for 3.45% surprise. Estimated earnings per share for the next quarter are -0.86 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CLDI earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise